News from the Foundation
While on the road this summer for the Reconnect Tour 2022, I met with academic and clinical centers of preeclampsia excellence whose leadership recognize that there is a gap between our pregnancy care and everything that happens beyond pregnancy.
Education Manager Maggie Barker recaps the 2022 Alliance for Innovation in Maternal Health Conference.
The Preeclampsia Foundation and the Preeclampsia Foundation Canada have announced that John Snelgrove, MD, MSc, and Samantha Wilson, PhD, are their 2022 Vision Grant research award recipients respectively.
CEO Eleni Z. Tsigas reflects on preeclampsia's impact on dads and how we can improve our support to empower them as partners in mom's health.
Investigators meeting the research funding program’s criteria are invited to submit Letters of Intent for 2022 proposals by August 22, 2022.
1665494821.png)
CEO Eleni Tsigas shares the first half of her ReConnect preeclampsia roadtrip, while asking the question: is innovation enough?
New research shows many patients not routinely educated about preeclampsia signs and symptoms during their pregnancy journey.
The Preeclampsia Foundation awarded these two-year grants to Brian Cox, PhD, Associate Professor at the University of Toronto Department of Physiology, and Amit Zeisel, PhD and Ido Solt, MD, Assistant Professors at Technion, Israel Institute of Techn...
The Preeclampsia Foundation announced today at the Society for Maternal-Fetal Medicine’s (SMFM) 42nd Annual Meeting – The Pregnancy Meeting™ – that applications are now being accepted for its 2022 Vision Grant program.
The Preeclampsia Foundation announced today that Merck for Mothers has awarded new funding for its program, MoMMA’s Voices, a national coalition of patient advocacy organizations and individuals with "lived experience" – or those that represent them....
A letter from incoming Board Chair Rakhi Dimino, MD, MMM, CPE about our vision for 2022.
1665516317.jpg)
The Preeclampsia Foundation welcomed a new group of officers to their 2022 Board of Directors today.